1-deoxynojirimycin has been researched along with lactic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, M; Fujiwara, H; Fujiwara, T; Higashioka, M; Kariya, T; Minatoguchi, S; Takatsu, H; Takemura, G; Uno, Y; Yoshikuni, Y | 1 |
| Arai, M; Fujiwara, H; Fujiwara, T; Hashimoto, K; Kariya, T; Kawasaki, M; Minatoguchi, S; Nishida, Y; Takemura, G; Uno, Y | 1 |
| Arai, M; Fujiwara, H; Fujiwara, T; Hashimoto, K; Hashimoto, Y; Minatoguchi, S; Nishida, Y; Takemura, G; Uno, Y; Wang, N; Wu, DJ | 1 |
| Arai, M; Chen, XH; Fujiwara, H; Fujiwara, T; Hashimoto, K; Minatoguchi, S; Nishida, Y; Takemura, G; Uno, Y; Wang, N | 1 |
| Achmatowicz, M; Hegedus, LS | 1 |
| Antel, JP; Avila-Pacheco, J; Blain, M; Borucki, DM; Chao, CC; Clish, CB; de Lima, KA; Gutiérrez-Vázquez, C; Hewson, P; Lipof, GZ; Liu, L; Mayo, L; Prat, A; Quintana, FJ; Rothhammer, V; Sanmarco, LM; Takenaka, MC; Tjon, EC; Trauger, SA; Wheeler, MA; Zandee, SEJ | 1 |
6 other study(ies) available for 1-deoxynojirimycin and lactic acid
| Article | Year |
|---|---|
N-methyl-1-deoxynojirimycin (MOR-14), an alpha-glucosidase inhibitor, markedly reduced infarct size in rabbit hearts.
Topics: 1-Deoxynojirimycin; Animals; Collateral Circulation; Enzyme Inhibitors; Glycogen; Glycoside Hydrolase Inhibitors; Hemodynamics; Lactic Acid; Male; Molecular Structure; Myocardial Infarction; Rabbits; Risk Factors | 1998 |
A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits.
Topics: 1-Deoxynojirimycin; Animals; Dose-Response Relationship, Drug; Glucosamine; Glycogen; Hemodynamics; Hypoglycemic Agents; Imino Pyranoses; Lactic Acid; Male; Myocardial Infarction; Myocardium; Rabbits | 1999 |
Combination of N-methyl-1-deoxynojirimycin and ischemic preconditioning markedly reduces the size of myocardial infarcts in rabbits.
Topics: 1-Deoxynojirimycin; Animals; Combined Modality Therapy; Disease Models, Animal; Enzyme Inhibitors; Glycogen; Glycoside Hydrolase Inhibitors; Heart Ventricles; Ischemia; Ischemic Preconditioning, Myocardial; Lactic Acid; Myocardial Infarction; Rabbits | 2001 |
N-methyl-1-deoxynojirimycin (MOR-14), an alpha-glucosidase inhibitor, markedly improves postischemic left ventricular dysfunction.
Topics: 1-Deoxynojirimycin; Adenosine Triphosphate; Animals; Blood Flow Velocity; Disease Models, Animal; Enzyme Inhibitors; Glycogen; Glycoside Hydrolase Inhibitors; Heart; Lactic Acid; Male; Myocardial Ischemia; Myocardial Reperfusion; Rats; Rats, Sprague-Dawley; Time Factors; Ventricular Dysfunction, Left | 2000 |
Synthesis of 1-deoxy-D-galactohomonojirimycin via enantiomerically pure allenylstannanes.
Topics: 1-Deoxynojirimycin; Aldehydes; Alkaloids; Catalysis; Cyclization; Galactose; Indicators and Reagents; Lactic Acid; Molecular Structure; Organometallic Compounds; Piperidines; Stereoisomerism; Tin | 2004 |
Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS.
Topics: 1-Deoxynojirimycin; Adaptor Proteins, Signal Transducing; Animals; Astrocytes; Brain; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Female; Hexokinase; Humans; Lactic Acid; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Phospholipases A2, Secretory | 2019 |